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Abstract
Musculoskeletal conditions, such as low back pain, are prevalent in the United States. These
conditions exact an enormous toll on society, both in terms of their detrimental impact on quality
of life and on the costs of treatment and lost productivity. Osteopathic physicians, as common
providers of primary care services and spinal manipulation, are ideally positioned to lead future
research efforts in this field. The emergence of data and standards relevant to osteopathic
manipulative treatment outcomes, refinement of research methodologies to enhance evidence-
based medicine, and investments in developing osteopathic research infrastructure are all critical
elements in moving this field of research forward.
The musculoskeletal research challenge
A few years ago, Deyo asked the rhetorical question,
"Where are the large trials involving dozens of practitioners
and thousands of patients that are commonplace in cardiovas-
cular disease and oncology and so scarce in musculoskeletal dis-
eases?" [1]. He concluded that, "The nearly ubiquitous
musculoskeletal conditions that 'merely' disable millions
deserve equal attention and scientifically rigorous study." [1].
Over 30 million ambulatory medical care visits annually
are attributed to low back pain in the United States [2].
Correspondingly, the costs attributable to low back pain
are enormous – exceeding $100 billion annually [3]. Con-
ducting research to identify more effective ways of treating
low back pain, particularly chronic low back pain, is a
national imperative that will have a major impact on
quality of life, health care expenditures, and work produc-
tivity.
The osteopathic profession is ideally positioned 
to respond to this challenge
Osteopathic physicians in the United States manage a dis-
proportionately large number of patients with low back
pain [2]. In so doing, osteopathic physicians serve dual
roles as providers of conventional medical treatment and
spinal manipulation [4]. This dichotomy may explain
why osteopathic physicians manage low back pain by pre-
scribing drugs and physical therapy less frequently than
allopathic physicians [2,5].
Data from the National Health Interview Survey (NHIS)
in 2007 indicate that 14.3 million adults used comple-
mentary and alternative medicine (CAM) therapies for
back pain within the past 12 months, making it by far the
leading reason for CAM therapy use [6]. Neck pain, joint
pain, and arthritis were the next three most common rea-
sons for using CAM therapies. Crude frequency data from
the 2007 NHIS also indicate that 36% of adults received
spinal manipulation provided by an osteopathic physi-
cian or chiropractor in the past 12 months, and that 66%
of these treatments were for back pain [7]. Many osteo-
pathic manipulative treatment (OMT) techniques, such as
high velocity-low amplitude thrusts, soft tissue tech-
niques, and articulatory techniques, are comparable to
those used by chiropractors and physical therapists [8].
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vided by these other practitioners.
The volume of patients with low back pain managed by
osteopathic primary care physicians and their dual roles
as conventional and CAM practitioners suggest that the
osteopathic profession is ideally positioned to respond to
Deyo's challenge, particularly as it pertains to spinal
manipulation for low back pain. The osteopathic profes-
sion should take the lead in providing the scientific evi-
dence base to establish the safety, efficacy, and
effectiveness of spinal manipulation in treating low back
pain and other musculoskeletal conditions. This should
involve a comprehensive approach, including basic sci-
ence research, translational research, clinical trials, and
comparative effectiveness studies.
The evolution of clinical practice guidelines and 
scientific knowledge gaps relating to spinal 
manipulation for low back pain
Although spinal manipulation has been used in treating
low back pain for over a century in the United States, the
Agency for Health Care Policy and Research did not issue
its seminal clinical practice guideline until 1994 [9]. It
concluded that: (1) spinal manipulation can be helpful
for patients with acute low back problems without radic-
ulopathy when used within the first month of symptoms;
and (2) in such patients having low back symptoms last-
ing more than one month, a trial of spinal manipulation
is probably safe, but of unproven efficacy. Investigators in
collaboration with the Cochrane Back Review Group sub-
sequently performed a systematic review and meta-analy-
sis and in 2003 concluded that spinal manipulation was
neither more nor less efficacious than other standard (i.e.,
conventional) medical treatments for low back pain [10].
A review of nonpharmacologic therapies for acute and
chronic low back in 2007 reported that the therapies with
good evidence of moderate efficacy for subacute or
chronic low back pain were cognitive behavioral therapy,
exercise, spinal manipulation, and interdisciplinary reha-
bilitation, whereas only superficial heat was associated
with good evidence of efficacy for acute low back pain
[11]. The joint practice guideline from the American Col-
lege of Physicians and the American Pain Society in 2007
recommended that clinicians consider adding spinal
manipulation in the treatment of patients with low back
pain who did not improve with self-care options [12]. It
did not address the addition of spinal manipulation in the
management of patients already receiving conventional
medical treatment for low back pain.
Thus, spinal manipulation has been promoted as an alter-
native to conventional medical treatment for low back
pain, but not as a complement to conventional medical
treatment. The lack of guidelines on complementary spi-
nal manipulation in the United States represents an
important scientific knowledge gap because patients often
seek conventional and CAM therapies concurrently.
In May 2009, the National Institute for Health and Clini-
cal Excellence (NICE) in the United Kingdom issued its
clinical guideline on the early management of persistent
non-specific low back pain [13]. A goal of this guideline is
to direct the management of low back pain in patients
whose pain has lasted more than six weeks, with the
objective of reducing disabling long-term back pain and
thereby mitigating the personal, social, and economic
impact of low back pain. The guideline recommended
considering up to nine sessions of spinal manipulation
over 12 weeks. It identified two other important research
questions: (1) what is the effect of providing sequential or
combination therapies when the initial monotherapy is
inadequate?; and (2) what is the cost-effectiveness of pro-
viding such combination therapies in patients with per-
sistent non-specific low back pain?
The current state of research on osteopathic 
manipulative treatment for low back pain
Most studies of spinal manipulation for low back pain
have focused on manipulation provided by chiropractors
or physical therapists, not by osteopathic physicians or
osteopaths. Although Goldstein challenged the osteo-
pathic profession in 1997 to embrace evidence-based
medicine [14], there have been no definitive mega-trials
of OMT completed to date. However, in 2005, a system-
atic review and meta-analysis of clinical trials specifically
addressed the use of OMT in treating low back pain [15].
The overall findings of this study indicated that subjects
who received OMT experienced a greater reduction in low
back pain compared with those subjects who did not
receive OMT. Similar OMT benefits were demonstrated in
a subgroup analysis comparing OMT with placebo or
active treatments. A commentary on this study concluded
that, "...it gives clear, although still preliminary, evidence that
OMT is much more than placebo," and recommended that
two sufficiently powered trials be conducted to better
delineate the magnitude of OMT effects [16].
The OSTEOPAThic Health outcomes In Chronic low back
pain (OSTEOPATHIC) Trial is a phase III clinical trial
using a randomized, double-blind, placebo-controlled, 2
× 2 factorial design to study the efficacy of OMT [17].
Ultrasound physical therapy is the other factor studied in
this trial. A total of 488 subjects (122 subjects allocated to
each of the four treatment dyads) are to be recruited. At
present, 770 participants have been screened, 349 subjects
have been randomized, and 258 subjects have completed
the trial.Page 2 of 4
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emerged to facilitate evidence-based medicine within the
realm of OMT. A re-analysis of data originally collected in
the North Texas Clinical Trial of OMT for chronic low
back pain [18] was performed to assess the existence of
the "OMT responder." Based on contemporaneous rec-
ommendations from the Cochrane Collaboration's Back
Editorial Board regarding clinically relevant effects [10],
and reported findings on the effects of placebo vs. no
treatment in clinical trials involving pain outcomes [19],
a 17-mm pain reduction on a 100-mm visual analogue
scale was established as the criterion for successful
response to OMT [20]. An international expert panel
recently corroborated this approach by recommending
minimally important changes on frequently used meas-
ures of pain and functional status for low back pain [21].
They considered 15 mm on a 100-mm visual analogue
scale, five units on the Roland-Morris Disability Ques-
tionnaire, and 10 units on the Oswestry Disability Index
to be minimally important absolute changes, and 30%
improvement from baseline to be a minimally important
relative change.
Having standards for minimally important changes ena-
bles the implementation of evidence-based medicine,
including the determination of such measures as number
needed to treat, number needed to harm, and likelihood
of help vs. harm as they pertain to OMT [22]. Using such
pain outcomes criteria, data from the North Texas Clinical
Trial suggest that about 50% of patients with chronic low
back pain may be successful responders to OMT within
three months of initiating treatment. Prognostic factor
analysis is another tool that can be used to identify signif-
icant predictors of successful response to OMT, and fur-
ther enable the development of clinical decision rules
[23]. The latter have the potential to inform not only
future research design, but also clinical practice [24].
Future directions for osteopathic research on 
musculoskeletal conditions
The spinal manipulation guidelines described above have
been driven by "efficacy" studies (phase II or phase III
clinical trials). Such studies generally include highly
selected subjects treated under rigid experimental proto-
cols. However, data are needed to corroborate the benefits
of spinal manipulation in real-world settings under less-
than-optimal conditions. Such "effectiveness" data, in
some ways analogous to pharmaceutical post-marketing
surveillance data (phase IV), are most efficiently collected
in observational studies. Consequently, new paradigms
are needed for extending research on OMT for muscu-
loskeletal conditions to include thousands of patients.
One such approach, for example, involves observation of
osteopathic physicians providing OMT to their patients
without the artificial constraints of a clinical trial proto-
col.
The Osteopathic Research Center (ORC) recently devel-
oped a framework for moving to this next step in muscu-
loskeletal research, with a focus on chronic low back pain.
The objectives of this ORC initiative include: (1) creating
a Consortium for Collaborative Osteopathic Research
Development (CONCORD); (2) training a cadre, initially
of 24 clinical research fellows, with specific interests in
OMT for chronic low back pain; and (3) developing a
national practice-based research network (PBRN) using
the clinical practices of these fellows. Ideally, the location
and clinical practice characteristics of each fellow could be
used to configure a geographically representative and
population-based PBRN for research in this field. An
inception cohort of 2,000 to 3,000 patients with non-spe-
cific chronic low back pain could be enrolled over two
years, providing data on clinical and laboratory findings.
The fellows' training would facilitate fidelity in document-
ing treatment interventions and measuring outcomes.
This framework would provide a foundation for planning
and implementing more rigorous studies as "spin-offs,"
including nested case-control studies, longitudinal stud-
ies, and clinical trials.
There is a great need for research involving the costs in
providing OMT for musculoskeletal conditions [25].
Because providing OMT requires a substantial investment
of physician time, often over many treatment sessions,
simply documenting less concomitant drug or physical
therapy use during the course of OMT may not be
accepted as evidence of value by the purchasers of health
care services. Cost-effectiveness analysis and cost-utility
analysis are two established methods that should be used
to study the cost implications of OMT.
Cost-utility analysis is particularly attractive for studying
the effects of OMT provided as a complement to conven-
tional medical treatment for low back pain. This approach
measures the incremental costs of OMT needed to achieve
an incremental improvement in health, often measured in
quality-adjusted life years (QALYs). The costs of providing
OMT in an ambulatory setting are often straightforward,
and either can be directly measured by the health care pro-
vider or estimated using explanation of benefits state-
ments or other third-party billing data. Recent advances in
econometric modeling have led to the development of
algorithms for converting common outcomes data, such
as the Medical Outcomes Study SF-36, into QALYs [26].
Thus, these two elements of a cost-utility analysis (incre-
mental OMT costs and incremental health benefits) can
be used to compare conventional medical treatment +
OMT with conventional medical treatment only in the
management of low back pain.Page 3 of 4
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Musculoskeletal conditions, such as low back pain, are
prevalent in the United States. These conditions exact an
enormous toll on society, both in terms of their detrimen-
tal impact on quality of life and on the costs of treatment
and lost productivity. Osteopathic physicians, as common
providers of primary care services and spinal manipula-
tion, are ideally positioned to lead future research efforts
in this field. The emergence of data and standards relevant
to OMT outcomes, refinement of research methodologies
to enhance evidence-based medicine, and investments in
developing osteopathic research infrastructure are all crit-
ical elements in moving this field of research forward.
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